Products for Research Use Only
RegisterLogin

BMS-P5

CAT: 0804-HY-137655-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-137655-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BMS-P5 is a selective and orally active peptidylarginine deiminase 4 (PAD4) inhibitor with an IC50 of 98 nM. BMS-P5 shows selective for PAD4 over PAD1, PAD2, and PAD3. BMS-P5 blocks multiple myeloma (MM) -induced neutrophil extracellular trap (NET) formation and delays progression of MM in a syngeneic mouse model[1].
CAS Number
1549811-36-0
UNSPSC
12352005
Target
Protein Arginine Deiminase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-p5.html
Purity
99.23
Solubility
DMSO : 35 mg/mL (ultrasonic)
Smiles
O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2.[H]Cl
Molecular Formula
C27H33ClN6O2
Molecular Weight
509.04
References & Citations
[1]Marina Li, et al. A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Mol Cancer Ther. 2020 Jul;19 (7) :1530-1538.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10716-01Exendin-P5
HY-P5803Pardaxin P5
HY-156693MTvkPABC-P5
HY-156693A-01MTvkPABC-P5 (TFA)
HY-P5803A-01Pardaxin P5 (TFA)
HY-P1887P5 Ligand for Dnak and DnaJ
HY-163099-01P5 (PEG24) -VC-PAB-Exatecan
HY-173625P5 (PEG12) -VC-PAB-Exatecan
HY-172736-01BMS-986458
HY-14225BMS-764459

Alternative Products

CatalogName
AMC37122-01BMS-P5
GTR19172831-01BMS-P5 free base
T79877-01MTvkPABC-P5
GTR19210817-01Aseanostatin P5
GTR19065941-01Exendin-P5
MBS5822107Pardaxin P5

Popular Products